<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12">
 <label>12.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zoppi</surname>
    <given-names>V.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hughes</surname>
    <given-names>S.J.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Maniaci</surname>
    <given-names>C.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Testa</surname>
    <given-names>A.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gmaschitz</surname>
    <given-names>T.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wieshofer</surname>
    <given-names>C.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Koegl</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Riching</surname>
    <given-names>K.M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Daniels</surname>
    <given-names>D.L.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Spallarossa</surname>
    <given-names>A.</given-names>
   </name>
   <etal>et al</etal>.
  </person-group>
  <article-title>Iterative design and optimization of initially inactive proteolysis targeting chimeras (PROTACs) identify VZ185 as a potent, fast, and selective von hippel-lindau (VHL) based dual degrader probe of BRD9 and BRD7</article-title>. 
  <source>J. Med. Chem.</source>
  <year>2019</year>; 
  <volume>62</volume>:
  <fpage>699</fpage>â€“
  <lpage>726</lpage>.
  <pub-id pub-id-type="pmid">30540463</pub-id>
 </mixed-citation>
</ref>
